| Document |
Document Title |
|
WO/2003/038523A2 |
Mixed carbocycle derivatives containing at least two carbocycles per molecule from the group of anthracenes, adamantanes and steroids with functionalized carbon chains are synthesized and used as modifiers of resist properties and especi...
|
|
WO/2003/035658A1 |
It is intended to provide a method of separating glycolipids (in particular, gangliosides) whereby a large number of samples can be conveniently and economically treated and many types of glycolipids can be collected at a high yield. Nam...
|
|
WO/2003/032905A2 |
Novel carbohydrate-based compounds with an attached ring system that have antimicrobial or cytostatic activity. The compounds are administered to humans and animals for the treatment or amelioration of bacterial, fungal, viral or protozo...
|
|
WO/2003/028709A2 |
The present invention relates to the use of peracylated N-acyl-mannosamine derivatives for the preparation of a medicament for stimulating neurite growth.
|
|
WO/2003/029263A1 |
The present invention provides new glucide derivatives of formula (I) or (II) having a biological activity as inducers of erythroid cell differentiation, constituted by an acyl moiety linked to a 3-deoxyglucide unit through an amine grou...
|
|
WO/2003/026677A1 |
Compositions are provided comprising chito-oligomers obtainable from chitin, comprising oligomers of N-acetyl glucosamine (NAG) and glucosamine, wherein at least 50% of the oligomers have a chain length of about 2-50, and the degree of d...
|
|
WO/2003/027060A1 |
It is intended to provide compounds represented by the following general formula (1), which show a higher selectivity for muscarinic receptor in smooth muscle than for muscarinic receptor in heart and have a potent antagonism, salts ther...
|
|
WO/2003/020736A1 |
The antibiotic drug clindamycin is provided as a crystalline free base. Three polymorphic/pseudopolymorphic forms of crystalline clindamycin free base are disclosed. Also provided are pharmaceutical compositions comprising crystalline cl...
|
|
WO/2003/018043A1 |
A partially purified plant extract for treating subjects who are hyperglycemic is provided. The partially-purified plant extract comprises a plurality of water soluble compounds having a molecular weight greater than 800 and less than 15...
|
|
WO/2003/014269A1 |
The invention relates to the use of polyesters consisting of at least one carbohydrate and at least one carboxylic acid, and mixtures of the same, as hydraulic fluid.
|
|
WO/2003/011844A2 |
The invention concerns a composition for perfluoroalkylation of an electrophilic substrate. Said composition comprises for successive or simultaneous addition: a) at least one of the compounds of formula (I) Rf-Z(O)¿n?-Y, wherein: Z rep...
|
|
WO/2003/009807A2 |
Cytoprotective compounds, many of which are phenolic derivatives characterized by a substituded phenol having certain conjugated bonds, are useful in the treatment of certain ischemic or inflammatory conditions, including but not limited...
|
|
WO/2003/006474A2 |
The invention relates to a method for producing peracylated 1-O-glycosides of general formula (I) or salts thereof, wherein sugar?1¿ is a monosaccharide which is functionalised in the 1-OH-position, R represents methyl, ethyl, propyl is...
|
|
WO/2003/000275A1 |
The present invention provides methods for obtaining gaultherin, a natural salicylate derivative, from plant tissue. The methods involve preventing the hydrolysis of the gaultherin in the plant tissue by disrupting the plant tissue under...
|
|
WO/2002/096921A1 |
A novel glucose derivative inducing apoptosis. The glucose derivative is represented by the following general formula (I) wherein X, Y and Z are the same or different and each is hydrogen, halogenoalkyl, hydroxy, or alkoxy, provided that...
|
|
WO/2002/090369A2 |
The invention relates to a method for the production of surface active agent mixtures containing alkyl/ and/or alkenyl oligoglycoside/ether carboxylic acids. The invention is characterized in that an aqueous solution from at least one al...
|
|
WO/2002/090370A1 |
An asymmetrically bicipital lipid which is represented by the general formula: R-NHCO-(CH¿2?)¿n?-COOH (I) wherein R represents a residue obtained by removing a reduced terminal hydroxyl group from an aldopyranose, n represents a number...
|
|
WO/2002/088156A1 |
A compound represented by the general formula (I) or a pharmacologically acceptable ester or salt thereof: (I) wherein one of R?1¿ and R?3¿ represents C¿9-15? alkyl and the other represents hydrogen or C¿1-6? alkyl; one of R?2¿ and ...
|
|
WO/2002/072110A1 |
The invention relates to novel active substances (caloporoside derivatives), which are formed by the microorganism Gloeoporus dichrous (Fr.:Fr.) Bres. ST001714, DSM 13784 during fermentation. The invention also relates to methods for pro...
|
|
WO2001040232A9 |
Novel C-13<2>-COXR1, C-17<2>-COXR2 and C-13<2>-COXR1, C-17<2>-COXR1 derivatives of chlorophyll and bacteriochlorophyll compounds are provided wherein X is O, S or N and R1 and R2 , the same or different, may be an optionally substituted ...
|
|
WO/2002/068436A1 |
The invention relates to avilamycin derivatives, genetic engineering, biosynthetic methods for the production thereof, medicaments containing said compounds and the utilization of said compounds for the production of a medicament against...
|
|
WO2002032915B1 |
The present invention provides a monosaccharide compound of general formula I as shown in the specification. The invention also provides processes for the preparation of the compound of formula I and methods of screening for antibacteria...
|
|
WO/2002/060975A1 |
Processes for the preparation of polyol fatty acid polyesters comprise heating a mixture of polyol, fatty acid ester, emulsifying agent and catalyst. In one embodiment, the fatty acid chains of the fatty acid ester have from about 6 to a...
|
|
WO/2002/057284A1 |
The present invention relates to novel compounds, the use of said compounds as a medicament as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal. Said gale...
|
|
WO/2002/057282A1 |
The present invention is a process for producing an aliphatic acid ester of carbohydrate comprising the steps of preparing an emulsion containing a salt of aliphatic acid and aqueous solution of carbohydrate or its derivative, obtening a...
|
|
WO/2002/053572A1 |
The invention relates to compounds which are useful in the delivery of a wide variety of therapeutically useful molecules. In particular, the invention relates to compounds which are able to act as carriers for therapeutically useful mol...
|
|
WO/2002/040060A2 |
The invention provides radiopharmaceuticals for diagnostic and therapeutic applications, conjugates of antioxidants with metal chelating ligands, intermediate compounds, methods of making such radiopharmaceuticals, ligands, and intermedi...
|
|
WO/2002/038530A1 |
A carboxylic acid type lipid which is a negatively charged lipid capable of stably donating negative charges to the surface of endoplasmic reticula without producing any side effect. It is represented by the following general formula [1]...
|
|
WO/2002/036600A2 |
In a composition comprising a therapeutic agent and a compound which is a trisaccharide or higher polysaccharide, that compound has the formula X[-Y-Z]¿n? wherein X and Z are each saccharide molecules in which none, some or all OH group...
|
|
WO/2002/032914A2 |
Acylated cellobiose compounds (CHME) which satisfy the formula:- wherein X represents an acyl group (R-CO-) or H, Z represents an acyl group (R'-CO-) or H and not more than a minority of X + Z residues represent H, R represents a saturat...
|
|
WO/2002/024715A2 |
The present invention provides compositions comprising at least one GHB moiety bonded to at least one physiologically compatible carrier molecule. The compositions can enhance the uptake of the drug, deliver effective therapeutic doses i...
|
|
WO/2002/022630A1 |
The present invention relates to compounds of formula (I) and phamaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of , and compositions containing such compoun...
|
|
WO/2002/018400A2 |
The present invention provides chemical processes for the preparation of disaccharide and trisaccharide C¿6? to C¿12? fatty acid esters having a high alpha content. Yet still further, the invention provides materials prepared by the pr...
|
|
WO/2002/010180A1 |
There is described a process for the synthesis of a sucrose-6-ester comprising: (a) reacting a mixture comprising sucrose and a polar aprotic solvent with an organotin-based acylation promoter, while adding a solvent capable of removing ...
|
|
WO/2002/002140A1 |
The present invention relates to the prophylactic treatment against, or therapeutic treatment of Th2-mediated diseases or disorders. Vaccines useful in these methods of treatment are provided. The vaccines comprise as active agent immuno...
|
|
WO/2001/090129A2 |
Methods and compositions for treating or ameliorating diseases and other conditions, such as infectious diseases, autoimmune diseases and allergies are provided. The methods employ mono- and disaccharide-based compounds for selectively s...
|
|
WO/2001/087309A1 |
Coumermycin analogs of general formula I: wherein X, a linking group, is selected from the group consisting of alkyl, aryl, diaryl, substituted alkyl, substituted aryl, alkyl with hereroatoms in the chain, heteroaryl, cyclic and bicyclic...
|
|
WO/2001/077122A1 |
This invention relates to novel highly functionalized phosphine ligands as ancillary ligands in radiopharmaceuticals. Also, this invention provides radiopharmaceuticals comprised of highly functionalized phosphine ligated ?99m¿Tc labele...
|
|
WO/2001/070209A2 |
Methods for treating diseases or conditions modulated or ameliorated by nitric oxide, particularly ischemia and reperfusion injury, are provided, using glycolipids structurally related to monophosphoryl lipid A but with notable reduction...
|
|
WO/2001/064699A1 |
6-Deoxy-6-carbonylthioglucopyranosyl acetimidates of the general formula (I) [wherein R?11¿, R?12¿ and R?13¿ are each independently alkyl or silyl; R?14¿ is hydrogen, alkyl, or aryl; R?15¿ is alkyl; and R?16¿ is hydrogen or alkyl]....
|
|
WO/2001/060835A1 |
The present invention relates to the compounds of the formula (I) and pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, composites containing, and t...
|
|
WO/2001/057053A1 |
The invention concerns a novel method for preparing by chemical process functionalised $g(b)-(1,3)-glucan derivatives, enabling to obtain free oligosaccharides or comprising specific groups such as, for instance, sulphate, phosphate, met...
|
|
WO/2001/054691A1 |
Nitrate salts of antimicrobial agents for the preparation of antimicrobial medicaments, specifically antiviral, antifungal and antibacterial medicaments.
|
|
WO/2001/051003A2 |
The invention provides novel methods for treating disease based on the medicinal use of lipids and phospholipids covalently bound to physiologically acceptable monomers or polymers. Phosphatidylethanolamine moieties conjugated to physiol...
|
|
WO/2001/051499A1 |
This invention relates to reagents and methods for synthesis of biologically active di- and tri-saccharides comprising $g(a)-D-Gal(1$m(7)3)-D-Gal. In particular the invention provides novel reagents, intermediates and processes for the s...
|
|
WO/2001/046210A1 |
A softening compound comprises a derivative of a cyclic polyol or a derivative of a reduced saccharide having, on average, 30 to 80 % ot its hydroxyl groups esterified and/or etherified, one or more long chain C¿8? to C¿22? alkyl, alke...
|
|
WO/2001/044263A1 |
This invention relates to the oligosaccharides with enhancing immune and antitumor activity. The described oligosaccharides have a main chain consisting of 3-14 sugar residues and side chains consisting of 0-4 sugar residues. The sugar r...
|
|
WO/2001/040240A2 |
The present invention relates to a novel family of monosaccharide derivatives and disaccharide derivatives and to a method of preparation thereof. A mono- and disaccharide derivatives according to the invention comprises at least one fat...
|
|
WO/2001/037790A1 |
Disclosed is the use of alkyl- and/or alkenyloligoglycoside fatty acid esters for improving the sensory evaluation of emulsions.
|
|
WO/2001/036436A1 |
A means and method for increasing or inhibiting the secretion of cytokines using gallotannins and ellagitannins is described. The preferred cytokine release inhibiting compounds are dimeric gallotannins having a linker molecule that misa...
|
